Wednesday, 11 December 2013

Teva seeking deals to build drug portfolio

Source: haaretz

Israel's Teva Pharmaceutical Industries, the world's biggest producer of generic drugs, is looking to step up the pace of deal-making as it braces for a slump in sales of top-selling multiple sclerosis drug Copaxone.  Read on